Pentacyclic triterpenes
United States Patent: 6,433,010
Glinski , et al. August 13, 2002
Abstract
The present invention relates to fungicidally effective compositions
containing at least one pentacyclic triterpene compound.
Pentacyclic triterpenes
United States Patent: 6,303,589
Glinski , et al. October 16, 2001
Abstract
The present invention relates to fungicidally effective compositions
containing at least one pentacyclic triterpene compound.
Subsituted Isocoumarins as Serine Protease Inhibitors and
Anti-Inflammatory Agents
United States Patent 5,324,648
Glinski , et al. Jun. 28, 1994
Abstract
Substituted isocoumarins, their use in inhibiting serine proteases with
trypsin-like, chymotrypsin-like and elastase-like specificity and their
roles as anti-inflammatory agents.
Quaternary Pyridinium Compounds and Uses Therefor
United States Patent 5,290,942
Glinski , et al. Mar. 1, 1994
Abstract
Quaternary pyridinium compounds for use as
acetylcholinesterase inhibitors of the following formulas:
METHOD OF TREATING CANCERS SENSITIVE TO
TREATMENT WITH WATER SOLUBLE DERIVATIVES OF TAXOL
United States Patent 5,157,049
Date of Patent: Oct. 20, 1992
Inventors
Rudiger D. Haugwitz, Bethesda, Md. Leon Zalkow, Atlanta, Ga.; Jan Glinski,
Ridgefield CT, Mathew Suffness, Silver Spring, Md.; Howard M. Deutsch,
Atlanta, Ga.; Venkatachala Narayanan
Abstract
The invention involves the treatment of cancer in humans by
administering water soluble derivatives of taxol. The types of cancer so
treatable are those sensitive to treatment with taxol.
QUATERNARY PYRIDINIUM COMPOUNDS
United States Patent 5,206,371
Date of Patent: Apr. 27, 1993
Inventors
James C. Powers; Sheldon W. May, both of Atlanta; Maria A. Hernandez,
Norcross, all of Ga.; Steve Thornton, Raleigh, N.C.; Jan Glinski, New
Fairfield, CT
Abstract
Quaternary pryidinium compounds, their use in inhibiting
acetylcholinesterase, their roles in the prophylaxis and treatment of
organophosphate poisoning, their roles in anticholinesterase therapy and
their roles as agents mimicking or opposing the actions of the natural
neurotransmitter acytylcholine.
Disclaimer: The documents above have been scanned using OCR (optical
character recognition), as a result of which some errors due exits. Please
contact us if you have found a discrepancy and would like us to fix the
mistake. We apologize for any inconvenience.
|
